Raffles Medical Group Ltd
RAFLF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $189 | $189 | $193 | $193 |
| % Growth | 0% | -2.1% | 0% | – |
| Cost of Goods Sold | $102 | $102 | $106 | $106 |
| Gross Profit | $87 | $87 | $87 | $87 |
| % Margin | 45.9% | 45.9% | 45.2% | 45.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $45 | $45 | $43 | $43 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $21 | $21 | $24 | $24 |
| Operating Expenses | $66 | $66 | $67 | $67 |
| Operating Income | $21 | $21 | $21 | $21 |
| % Margin | 11% | 11% | 10.7% | 10.7% |
| Other Income/Exp. Net | $1 | $1 | $1 | $1 |
| Pre-Tax Income | $22 | $22 | $22 | $22 |
| Tax Expense | $6 | $6 | $6 | $6 |
| Net Income | $16 | $16 | $16 | $16 |
| % Margin | 8.5% | 8.5% | 8.2% | 8.2% |
| EPS | 0.009 | 0.009 | 0.009 | 0.009 |
| % Growth | 0% | 2.4% | 0% | – |
| EPS Diluted | 0.009 | 0.009 | 0.009 | 0.009 |
| Weighted Avg Shares Out | 1,856 | 1,856 | 1,860 | 1,860 |
| Weighted Avg Shares Out Dil | 1,857 | 1,857 | 1,858 | 1,858 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $10 | $10 | $6 | $6 |
| EBITDA | $31 | $31 | $28 | $28 |
| % Margin | 16.5% | 16.5% | 14.2% | 14.2% |